Regulation of transcription factor activity by extracellular signals in epidermal keratinocytes

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 12, Issue 1, 2003, Pages 3-14

  Rao, Laxmi S ^a   Long, Wendy S ^a   Kaneko, Takehiko ^a,b   Blumenberg, Miroslav ^c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activity regulation; Epidermal keratinocytes; Extracellular sinals; Transcription factors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CELL EXTRACT; CYTOKINE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOSTATIN M; PHOSPHORUS 32; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING ASSAY; CELL ACTIVATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; CULTURE MEDIUM; EPIDERMIS CELL; FETAL CALF SERUM; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; OLIGONUCLEOTIDE PROBE; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 0037353769     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Blumenberg M, Tomic-Canic M. Human epidermal keratinocyte: keratinization processes. In: P. Jolles HZaHH, editor. Formation and Structure of Human Hair. Volume 78. Basel: Birkhauser Verlag; 1997. p 1-29.
2. Fuchs E. Epidermal differentiation: The bare essentials. J Cell Biol 1990; 111: 2807-14.
3. Eckert RL. Structure, function, and differentiation of the keratinocyte. Physiol Rev 1989; 69: 1316-46.
4. Kupper TS. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 1990; 94: 146S-150S.
5. Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ. Keratinocytes as initiators of inflammation. Lancet 1991; 337: 211-4.
6. Pittelkow MR, Coffey R, Jr., Moses HJ. Keratinocytes produce and are regulated by transforming growth factors. Ann New York Acad Sci 1988; 548: 211-24.
7. Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M. Keratins and the Keratinocyte Activation Cycle. J Invest Dermatol 2001; 116: 633-40.
8. Blumenberg M. Keratinocytes: Biology and Differentiation. In: al. KAe, editor. Cutaneous Medicine and Surgery. Volume 1. Philadelphia: W.B. Saunders Co.; 1994. p 58-74.
9. Grinnell F. Wound repair, keratinocyte activation and integrin modulation. J Cell Sci 1992; 101: 1-5.
10. Schafer IA, Kovach M, Price RL, Fratianne RB. Human keratinocytes cultured on collagen gels form an epidermis which synthesizes bullous pemphigoid antigens and alpha 2 beta 1 integrins and secretes laminin, type IV collagen, and heparan sulfate proteoglycan at the basal cell surface. Exp Cell Res 1991; 195: 443-57.
11. Barker JN, MacDonald DM. Cutaneous lymphocyte trafficking in the inflammatory dermatoses. Brit J Dermatol 1992; 126: 211-5.
12. Cornelius LA, Taylor JT, Degitz K, Li LJ, Lawley TJ, Caughman SW. A 5′ portion of the ICAM-1 gene confers tissue-specific differential expression levels and cytokine responsiveness. J Invest Dermatol 1993; 100: 753-8.
13. O'Keefe EJ, Woodley DT, Falk RJ, Gammon WR, Briggaman RA. Production of fibronectin by epithelium in a skin equivalent. J Invest Dermatol 1987; 88: 634-9.
14. Komine M, Rao LS, Kaneko T, Tomic-Canic M, Tamaki K, Freedberg IM, Blumenberg M. Inflammatory versus proliferative processes in epidermis. Tumor necrosis factor alpha induces K6b keratin synthesis through a transcriptional complex containing NF kappa B and C/EBP beta. J Biol Chem 2000; 275: 32077-88.
15. Komine M, Rao ES, Freedberg IM, Simon M, Milisavljevic V, Blumenberg M. Interleukin-1 induces transcription of keratin K6 in human epidermal keratinocytes. J Invest Dermatol 2001; 116: 330-8.
16. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203-12.
17. Hill CS, Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 1995; 80: 199-211.
18. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129-57.
19. Karin M. The regulation of AP-1 activity by mitogen- activated protein kinases. Philosl Trans R Soc of London: Biological Sciences 1996; 351: 127-34.
20. Klampfer L, Lee TH, Hsu W, Vilcek J, Chen-Kiang S. NF-IL6 and AP-1 cooperatively modulate the activation of the TSG-6 gene by tumor necrosis factor alpha and interleukin-1. Mol Cell Biol 1994; 14: 6561-9.
21. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993; 7: 2135-48.
22. Dérijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNKI: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76: 1025-37.
23. Bernerd F, Magnaldo T, Freedberg IM, Blumenberg M. Expression of the carcinoma-associated keratin K6 and the role of AP-1 proto-oncoproteins. Gene Expression 1993; 3: 187-99.
24. Basset-Seguin N, Demoly P, Moles JP, Tesnieres A, Gauthier-Rouviere C, Richard S, Blanchard JM, Guilhou JJ. Comparative analysis of cellular and tissular expression of c-fos in human keratinocytes: evidence of its role in cell differentiation. Oncogene 1994; 9: 765-71.
25. Rutberg SE, Saez E, Glick A, Dlugosz AA, Spiegelman BM, Yuspa SH. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. Oncogene 1996; 13: 167-76.
26. Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH, Spiegelman BM. c-fos is required for malignant progression of skin tumors. Cell 1995; 82: 721-32.
27. Miyamoto S, Verma IM. Rel/NF-kappa B/I kappa B story. Advances in Cancer Res 1995; 66: 255-92.
28. Beg AA, Finco TS, Nantermet PV, Baldwin A, Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol 1993; 13: 3301-10.
29. Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. New England J Med 1997; 336: 1066-71.
30. Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt Ph, Chen Ch, Rosen CA, Stewart CL. I kappa B alpha deficiency results in a sustained NF-kappa B response and severe widespread dermatitis in mice. Mol Cell Biol 1996; 16: 2341-9.
31. Matsusaka T, Fujikawa K,Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A 1993; 90: 10193-7.
32. Stein B, Baldwin A, Jr., Ballard DW, Greene WC, Angel P, Herrlich P. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 1993; 12: 3879-91.
33. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1997; 9: 1897-906.
34. Trautwein C, Caelles C, van der Geer R Hunter T, Karin M, Chojkier M. Transactivation by NT-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 1993; 364: 544-7.
35. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci U S A 1993; 90: 2207-11.
36. Nishio Y, Isshiki H, Kishimoto T, Akira S. A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction. Mol Cell Biol 1993; 13: 1854-62.
37. Chen P, Riley DJ, Chen Y, Lee WH. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev 1996; 10: 2794-804.
38. Mink S, Mutschler B, Weiskirchen R, Bister K, Klempnauer Kh. A novel function for Myc: inhibition of C/EBP-dependent gene activation. Proc Natl Acad Sci U S A 1996; 93: 6635-40.
39. Maytin EV, Habener JF. Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J Invest Dermatol 1998; 110: 238-46.
40. Stein B, Cogswell PC, Baldwin A, Jr. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-b ZIP interaction. Mol Cell Biol 1993; 13: 3964-74.
41. Brasier A, Ron D, Tate J, Habener J. A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced, NF kappa B mediated trans-activation of the angiotensinogen gene acute-phase response element. EMBO J 1990; 9: 3933-44.
42. Baldwin A, Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Ann Rev Immunol 1996; 14: 649-83.
43. Kadonaga JT, Tjian R. Affinity purification of sequence-specific DNA binding proteins. Proc Natl Acad Sci U S A 1986; 83: 5889-93.
44. Kingsley C, Winoto A. Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol Cell Biol 1992; 12: 4251-61.
45. Nehls MC, Rippe RA, Veloz L, Brenner DA. Transcription factors nuclear factor I and Sp 1 interact with the murine collagen alpha 1 (I) promoter. Mol Cell Biol 1991; 11: 4065-73.
46. Janson L, Pettersson U. Cooperative interactions between transcription factors Sp1 and OTF-1. Proc Natl Acad Sci U S A 1990; 87: 4732-6.
47. Gegonne A, Bosselut R, Bailly RA, Ghysdael J. Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1. EMBO J 1993; 12: 1169-78.
48. Mastrangelo IA, Courey AJ, Wall JS, Jackson SP, Hough PVC. DNA looping and Sp1 multimer links: A mechanism for transcriptional synergism and enhancement. Proc Natl Acad Sci U S A 1991; 88: 5670-4.
49. Ohtsuki M, Flanagan S, Freedberg IM, Blumenberg M. A cluster of five nuclear proteins regulates keratin transcription. Gene Expression 1993; 3: 201-13.
50. Fischer DF, Gibbs S, van De Putte P, Backendorf C. Interdependent transcription control elements regulate the expression of the SPRR2A gene during keratinocyte terminal differentiation. Mol Cell Biol 1996; 16: 5365-74.
51. Milisavljevic V, Freedberg IM, Blumenberg M. Characterization of nuclear protein binding sites in the promoter of keratin K17 gene. DNA & Cell Biol 1996; 15: 65-74.
52. Magnaldo T, Bernerd F, Freedberg IM, Ohtsuki M, Blumenberg M. Transcriptional regulators of expression of K#16, the disease-associated keratin. DNA and Cell Biology 1993; 12: 911-23.
53. Schindler C, Darnell J, Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Ann Rev Biochem 1995; 64: 621-51.
54. Pittelkow MR, Lindquist PB, Abraham RT, Graves-Deal R, Derynck R, Coffey R, Jr. Induction of transforming growth factor-alpha expression in human keratinocytes by phorbol esters. J Biol Chem 1989; 264: 5164-71.
55. Jiang CK, Magnaldo T, Ohtsuki M, Freedberg IM, Bernerd F, Blumenberg M. Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferation-associated keratins 6 and 16. Proc Natl Acad Sci U S A 1993; 90: 6786-90.